Literature DB >> 29680254

Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.

Sang Ho Lee1, Andreas Rimner2, Emily Gelb2, Joseph O Deasy1, Margie A Hunt1, John L Humm1, Neelam Tyagi3.   

Abstract

PURPOSE: To correlate semiquantitative parameters derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Twenty-four NSCLC patients who underwent pretreatment 18F-FDG-PET and DCE-MRI were analyzed. The maximum standardized uptake value (SUVmax) was measured from 18F-FDG-PET. Dynamic contrast-enhanced MRI was obtained on a 3T MRI scanner using 4-dimensional T1-weighted high-resolution imaging with a volume excitation sequence. The DCE-MRI parameters, consisting of mean, median, standard deviation (SD), and median absolute deviation (MAD) of peak enhancement, time to peak (TTP), time to half peak (TTHP), wash-in slope (WIS), wash-out slope (WOS), initial gradient, wash-out gradient, signal enhancement ratio, and initial area under the relative signal enhancement curve taken up to 30, 60, 90, 120, 150, and 180 seconds, TTP, and TTHP (IAUCtthp), were calculated for each lesion. Univariate analysis (UVA) was performed using Spearman correlation. A linear regression model to predict SUVmax from DCE-MRI parameters was developed by multivariate analysis (MVA) using least absolute shrinkage selection operator in combination with leave-one-out cross-validation (LOOCV).
RESULTS: In UVA, mean(WOS) (ρ = -0.456, P = .025), mean(IAUCtthp) (ρ = -0.439, P = .032), median(IAUCtthp) (ρ = -0.543, P = .006), and MAD(IAUCtthp) (ρ = -0.557, P = .005) were statistically significant; all these parameters were negatively correlated with SUVmax. In MVA, a linear combination of SD(WIS), SD(TTP), MAD(TTHP), and MAD(IAUCtthp) was statistically significant for predicting SUVmax (LOOCV-based adjusted R2 = 0.298, P = .0006). A decrease in SD(WIS), MAD(TTHP), and MAD(IAUCtthp) and an increase in SD(TTP) were associated with a significant increase in SUVmax.
CONCLUSION: An association was found between SUVmax, the SD, and MAD of DCE-MRI metrics derived during contrast uptake in NSCLC, reflecting that intratumoral heterogeneity in wash-in contrast kinetics is associated with tumor metabolism. Although MAD(IAUCtthp) was a significant feature in both UVA and MVA, the LASSO-based multivariate regression model yielded better predictability of SUVmax than a univariate regression model using MAD(IAUCtthp). This study will facilitate understanding of the complex relationship between tumor vascularization and metabolism and eventually help in guiding targeted therapy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29680254      PMCID: PMC6119645          DOI: 10.1016/j.ijrobp.2018.02.031

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  33 in total

1.  Non-small-cell lung cancer--stalemate or progress?

Authors:  D N Carney; H H Hansen
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

Review 2.  Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies.

Authors:  James P B O'Connor; Alan Jackson; Geoff J M Parker; Caleb Roberts; Gordon C Jayson
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675

3.  Multiparametric imaging of tumor response to therapy.

Authors:  Anwar R Padhani; Kenneth A Miles
Journal:  Radiology       Date:  2010-08       Impact factor: 11.105

4.  Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies.

Authors:  Caleb Roberts; Basma Issa; Andrew Stone; Alan Jackson; John C Waterton; Geoffrey J M Parker
Journal:  J Magn Reson Imaging       Date:  2006-04       Impact factor: 4.813

5.  Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy.

Authors:  Yohei Imamura; Koichi Azuma; Seiji Kurata; Satoshi Hattori; Tetsuro Sasada; Takashi Kinoshita; Masaki Okamoto; Tomotaka Kawayama; Hayato Kaida; Masatoshi Ishibashi; Hisamichi Aizawa
Journal:  Lung Cancer       Date:  2010-04-28       Impact factor: 5.705

6.  Pathophysiologic basis of contrast enhancement in breast tumors.

Authors:  M V Knopp; E Weiss; H P Sinn; J Mattern; H Junkermann; J Radeleff; A Magener; G Brix; S Delorme; I Zuna; G van Kaick
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

7.  Detecting recurrent or residual lung cancer with FDG-PET.

Authors:  T Inoue; E E Kim; R Komaki; F C Wong; P Bassa; W H Wong; D J Yang; K Endo; D A Podoloff
Journal:  J Nucl Med       Date:  1995-05       Impact factor: 10.057

8.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

9.  Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.

Authors:  Ie Ryung Yoo; Soo Kyo Chung; Hye Lim Park; Woo Hee Choi; Young Kyoon Kim; Kyo Young Lee; Young-Pil Wang
Journal:  Biomed Mater Eng       Date:  2014       Impact factor: 1.300

10.  Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.

Authors:  Zachary D Horne; David A Clump; John A Vargo; Samir Shah; Sushil Beriwal; Steven A Burton; Annette E Quinn; Matthew J Schuchert; Rodney J Landreneau; Neil A Christie; James D Luketich; Dwight E Heron
Journal:  Radiat Oncol       Date:  2014-01-30       Impact factor: 3.481

View more
  3 in total

1.  Diagnosis of spinal lesions using perfusion parameters measured by DCE-MRI and metabolism parameters measured by PET/CT.

Authors:  Jiahui Zhang; Yongye Chen; Yanyan Zhang; Enlong Zhang; Hon J Yu; Huishu Yuan; Yang Zhang; Min-Ying Su; Ning Lang
Journal:  Eur Spine J       Date:  2019-11-21       Impact factor: 3.134

Review 2.  A review of the role of MRI in diagnosis and treatment of early stage lung cancer.

Authors:  Austin J Sim; Evangelia Kaza; Lisa Singer; Stephen A Rosenberg
Journal:  Clin Transl Radiat Oncol       Date:  2020-06-06

3.  Feasibility of semiquantitative 18F-fluorodeoxyglucose PET/computed tomography in patients with advanced lung cancer for interim treatment evaluation of combining immunotherapy and chemotherapy.

Authors:  Linping Ke; Leilei Wu; Jinming Yu; Xue Meng
Journal:  Nucl Med Commun       Date:  2021-09-01       Impact factor: 1.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.